Goldman Sachs’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-215
| Closed | -$2K | – | 5270 |
|
|
2022
Q3 | $2K | Sell |
215
-4,668
| -96% | -$43.4K | ﹤0.01% | 5400 |
|
|
2022
Q2 | $74K | Buy |
4,883
+3,098
| +174% | +$46.9K | ﹤0.01% | 5193 |
|
|
2022
Q1 | $123K | Sell |
1,785
-2,289
| -56% | -$158K | ﹤0.01% | 5244 |
|
|
2021
Q4 | $246K | Buy |
4,074
+972
| +31% | +$58.7K | ﹤0.01% | 4883 |
|
|
2021
Q3 | $406K | Sell |
3,102
-116
| -4% | -$15.2K | ﹤0.01% | 4498 |
|
|
2021
Q2 | $852K | Buy |
3,218
+1,449
| +82% | +$384K | ﹤0.01% | 4123 |
|
|
2021
Q1 | $595K | Buy |
1,769
+828
| +88% | +$278K | ﹤0.01% | 4241 |
|
|
2020
Q4 | $318K | Sell |
941
-2,829
| -75% | -$956K | ﹤0.01% | 4053 |
|
|
2020
Q3 | $1.41M | Sell |
3,770
-2,588
| -41% | -$969K | ﹤0.01% | 3104 |
|
|
2020
Q2 | $3.34M | Sell |
6,358
-2,335
| -27% | -$1.23M | ﹤0.01% | 2561 |
|
|
2020
Q1 | $3.82M | Buy |
8,693
+7,344
| +544% | +$3.22M | ﹤0.01% | 2418 |
|
|
2019
Q4 | $248K | Sell |
1,349
-677
| -33% | -$124K | ﹤0.01% | 3921 |
|
|
2019
Q3 | $385K | Buy |
2,026
+1,476
| +268% | +$280K | ﹤0.01% | 3692 |
|
|
2019
Q2 | $175K | Sell |
550
-486
| -47% | -$155K | ﹤0.01% | 3910 |
|
|
2019
Q1 | $428K | Sell |
1,036
-386
| -27% | -$159K | ﹤0.01% | 3618 |
|
|
2018
Q4 | $347K | Buy |
1,422
+198
| +16% | +$48.3K | ﹤0.01% | 3545 |
|
|
2018
Q3 | $603K | Buy |
1,224
+569
| +87% | +$280K | ﹤0.01% | 3388 |
|
|
2018
Q2 | $449K | Buy |
655
+232
| +55% | +$159K | ﹤0.01% | 3573 |
|
|
2018
Q1 | $334K | Buy |
423
+169
| +67% | +$133K | ﹤0.01% | 3662 |
|
|
2017
Q4 | $235K | Buy |
+254
| New | +$235K | ﹤0.01% | 3761 |
|